Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses <i>in vitro</i>.

Authors:
Segatto NV; Simões LD; Bender CB; Sousa FS; Oliveira TL and 16 more

Journal:
Front Oncol

Publication Year: 2024

DOI:
10.3389/fonc.2024.1323422

PMCID:
PMC10926022

PMID:
38469237

Journal Information

Journal Title: Front Oncol

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"microarray data is available at the gene expression omnibus archive (geoarchive) under accession number (gse255187) 2 10 3 microarray slide analysis was performed in the software genespring gx (agilent technologies inc santa clara ca usa)."

Code Sharing
Evidence found in paper:

"Conflict of interest LBS, LJ, CB, and KS work for Sus Clinicals, which provides the Oncopig and other pig-based preclinical testing services to customers. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by grants from CNPq, CAPES (Financial code 7100 and 9161), and FAPERGS (DOCFIX 04/2018). CNPq is also acknowledged for the fellowship to FS and TC."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025